Inclusion Criteria:
  1. Positive hepatitis b surface antigen or hepatitis b virus DNA > 0.5 year;
  2. Age from 18 to 55 years old;
  3. Fibrosis lever of F1 to F3 from liver biopsy; if liver biopsy unreachable, fibrosis lever of 7 to 14 kpa from fibroscan;
  4. Portal vein diameter ≤ 12 mm from liver ultrasound;
  5. Receiving treatment of nucleoside/nucleotide analogues at the past one year;
  6. Normal liver function;
  7. Undetectable hepatitis b virus DNA.
Exclusion Criteria:
  1. Decompensated cirrhosis, hepatocellular carcinoma or other malignancy;
  2. Pregnancy or lactation;
  3. Other active liver diseases；
  4. Human immunodeficiency virus infection or congenital immune deficiency diseases;
  5. Severe diabetes, autoimmune diseases;
  6. Other important organ dysfunctions;
  7. Patients can not follow-up;
  8. Investigator considering inappropriate.